Has Sameer Avasarala, MD received payments from drug or device companies?

Yes. Drug and device makers reported $23,715 in general payments to Sameer Avasarala, MD across 59 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sameer Avasarala, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sameer Avasarala, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sameer Avasarala, MD

Pulmonary Disease · Nashville, TNNPI 1255673604

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $14,659 of the $23,715 with a category attached, or 61.8%. 18 manufacturers reported payments, led by Johnson & Johnson at 37.6% of the total. 2025 is the largest year on record at $12,272, 4.4 times the $2,766 reported in 2019. Among pulmonary disease clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,715in general payments, 2019–2025

Across 59 payments — averaging $401.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$9K
Medical Device Business Services, Inc.$6K
Intuitive Surgical$4K
Covidien LP$3K
Pinnacle Biologics, Inc$600
Noah Medical Corporation$408
plus $1K from 12 others

What the payments were for

Consulting fees$14,65962%
Travel & lodging$3,60115%
Food & beverage$2,95512%
Education$2,50011%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	14	$8,923
Medical Device Business Services, Inc.	5	$6,141
Intuitive Surgical	8	$3,602
Covidien LP	7	$2,755
Pinnacle Biologics, Inc	2	$600
Noah Medical Corporation	5	$408
Pulmonx Corporation	3	$398
Medtronic	3	$322
Ethicon Endo-surgery Inc.	2	$217
Steris Corporation	1	$158
Olympus America Inc.	1	$45
Amgen	2	$35
Olympus Corporation Of The Americas	1	$26
Harmony Biosciences LLC	1	$25
AstraZeneca	1	$16
Insmed, Inc.	1	$16
Jazz Pharmaceuticals Inc.	1	$14
Merck	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,715 in reported general payments places this provider in the 90th percentile of 339 pulmonary disease providers in Tennessee.

See all pulmonary disease providers in Tennessee →

Medicare billing

Part B allowed, 2024

$40,588

Medicare patients

150

Services billed

323

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	13	$10,883
Albuterol Sulfate HfaAlbuterol Sulfate	40	$904
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	18	$729
Prednisone	32	$171
Montelukast Sodium	14	$5

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Nashville

Lisa LancasterNashville$519K
Otis RickmanNashville$392K
Susan GarwoodNashville$343K
Joao DeandradeNashville$245K
Anna HemnesNashville$183K
Bryan HayNashville$126K
Karl KuhnNashville$106K
Fabien MaldonadoNashville$83K
Margaret SalisburyNashville$53K
Victor KhaNashville$44K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →